Cytokinetics Income Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Revenue | 12.4 | 13.6 | 3.1 |
| Cost of Goods Sold | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 15.1 | 16.7 | 15.2 |
| Depreciation & Amortization | 2.5 | 2.8 | 2.9 |
| Operating Income | -- | -- | -- |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 0.0 | -- | -- |
| Nonoperating Expenses | 2.7 | -- | -- |
| Income Before Taxes | -- | -- | -- |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | 0.0 | 0.0 | 0.0 |
| Continuing Operations | (56.4) | (48.9) | (57.1) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (56.4) | (48.9) | (57.1) |
| Total Net Income | (56.4) | (48.9) | (57.1) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (1.14) | (1.03) | (1.56) |
| Dividends per Share | 0.00 | 0.00 | 0.00 |
© 2009 Morningstar, Inc. Financial Data provided by
